Pitfalls and problems of relying on serum troponin

QJM. 2005 May;98(5):365-71. doi: 10.1093/qjmed/hci055. Epub 2005 Apr 8.

Abstract

Cardiac troponin (cT) is released after myocardial damage. In the appropriate clinical setting, a measured elevation of cT can increase the diagnostic rate of myocardial infarction and acute coronary syndrome. Elevations of cT, however, can occur in a wide variety of other clinical situations. Failure to recognize this can lead to an over-diagnosis of myocardial infarction (MI). We present clinical cases from our institution that illustrate this diagnostic problem, and review similar cases in the literature. We also discuss the implications of an erroneous diagnosis of myocardial infarction, for the patient and for the health services.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Biomarkers / blood
  • Cardiomyopathy, Dilated / blood
  • Cardiomyopathy, Dilated / diagnosis
  • Cholecystitis / blood
  • Cholecystitis / diagnosis
  • Coronary Disease / blood
  • Coronary Disease / diagnosis*
  • Diagnosis, Differential
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / blood
  • Myocardial Infarction / diagnosis*
  • Pulmonary Embolism / blood
  • Pulmonary Embolism / diagnosis
  • Sensitivity and Specificity
  • Troponin / blood*

Substances

  • Biomarkers
  • Troponin